Says confident in ability to “fully mitigate” tariff impacts. Says most products made in U.S., only a small amount shipped to China and subject to tariffs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
- QuidelOrtho says capital allocation priority remains paydown of debt
- QuidelOrtho says company actions ‘sufficient’ to mitigate tariff impacts
- QuidelOrtho sees FY25 Labs business growth in mid-single digits
- QuidelOrtho says $30M-$40M of tariff impacts to be mitigated by cost actions
- QuidelOrtho backs FY25 adjusted EPS view 2.07-$2.57, consensus $2.34